BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17212767)

  • 1. Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice.
    Ramos-Avila A; Ventura-Gallegos JL; Zentella-Dehesa A; Machuca-Rodríguez C; Moreno-Altamirano MM; Narváez V; Legorreta-Herrera M
    Scand J Immunol; 2007 Jan; 65(1):54-62. PubMed ID: 17212767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XL-infected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug?
    Legorreta-Herrera M; Retana-Ugalde R; Ventura-Gallegos JL; Narváez V
    Exp Parasitol; 2010 Nov; 126(3):381-8. PubMed ID: 20193682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
    Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
    Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
    Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
    Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.
    Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A
    Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment during a primary malaria infection modifies the development of cross immunity.
    Legorreta-Herrera M; Ventura-Ayala ML; Licona-Chávez RN; Soto-Cruz I; Hernández-Clemente FF
    Parasite Immunol; 2004 Jan; 26(1):7-17. PubMed ID: 15198641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
    Wang QH; Liu YJ; Liu J; Chen G; Zheng W; Wang JC; Cao YM
    Exp Parasitol; 2009 Mar; 121(3):268-73. PubMed ID: 19109953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
    Zheng W; Liu J; Meng DY; Hu XF; Cao YM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Plasmodium berghei yoelii in chloroquine- and pyrimethamine-treated mice.
    Pradhan VR; Renapurkar DM
    Folia Parasitol (Praha); 1984; 31(4):371-3. PubMed ID: 6510839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection.
    Guha M; Maity P; Choubey V; Mitra K; Reiter RJ; Bandyopadhyay U
    J Pineal Res; 2007 Nov; 43(4):372-81. PubMed ID: 17910606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) Treg in mice.
    Tetsutani K; Ishiwata K; Ishida H; Tu L; Torii M; Hamano S; Himeno K; Hisaeda H
    Eur J Immunol; 2009 Oct; 39(10):2822-30. PubMed ID: 19728313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative histopathology of mice infected with the 17XL and 17XNL strains of Plasmodium yoelii.
    Fu Y; Ding Y; Zhou TL; Ou QY; Xu WY
    J Parasitol; 2012 Apr; 98(2):310-5. PubMed ID: 22017443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of ammonia, glutamate, lactate and pyruvate during Plasmodium yoelii infection and pyrimethamine treatment in mice.
    Agarwal A; Tripathi LM; Pandey VC
    J Commun Dis; 1997 Sep; 29(3):235-41. PubMed ID: 9465528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of α-tocopheryloxy acetic acid, a vitamin E derivative mitocan, on the experimental infection of mice with Plasmodium yoelii.
    Kawamura K; Kume A; Umemiya-Shirafuji R; Kasai S; Suzuki H
    Malar J; 2021 Jun; 20(1):280. PubMed ID: 34167535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.
    Wagner A; Förster-Waldl E; Garner-Spitzer E; Schabussova I; Kundi M; Pollak A; Scheiner O; Joachim A; Wiedermann U
    Int J Parasitol; 2009 Mar; 39(4):465-72. PubMed ID: 18938169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.